Risk factors for progression of brain atrophy in aging: six-year follow-up of normal subjects
- PMID: 15911795
- DOI: 10.1212/01.WNL.0000161871.83614.BB
Risk factors for progression of brain atrophy in aging: six-year follow-up of normal subjects
Abstract
Objectives: To determine the rate of brain atrophy in neurologically asymptomatic elderly and to investigate the impact of baseline variables including conventional cerebrovascular risk factors, APOE epsilon4, and white matter hyperintensity (WMH) on its progression.
Methods: We assessed the brain parenchymal fraction at baseline and subsequent annual brain volume changes over 6 years for 201 participants (F/M = 96/105; 59.8 +/- 5.9 years) in the Austrian Stroke Prevention Study from 1.5-T MRI scans using SIENA (structural image evaluation using normalization of atrophy)/SIENAX (an adaptation of SIENA for cross-sectional measurement)(www.fmrib.ox.ac.uk/fsl). Hypertension, cardiac disease, diabetes mellitus, smoking, and regular alcohol intake were present in 64 (31.8%), 60 (29.9%), 5 (2.5%), 70 (39.3%), and 40 (20.7%) subjects, respectively. Plasma levels of fasting glucose (93.7 +/- 18.6 mg/dL), glycated hemoglobin A (HbA1c; 5.6 +/- 0.7%), total cholesterol (228.3 +/- 40.3 mg/dL), and triglycerides (127.0 +/- 75.2 mg/dL) were determined. WMH was rated as absent (n = 56), punctate (n = 120), early confluent (n = 14), and confluent (n = 11).
Results: The baseline brain parenchymal fraction of the entire cohort was 0.80 +/- 0.02 with a mean annual brain volume change of -0.40 +/- 0.29%. Univariate analysis demonstrated a higher rate of brain atrophy in older subjects (p = 0.0001), in those with higher HbA1c (p = 0.0001), higher body mass index (p = 0.02), high alcohol intake (p = 0.04), severe WMH (p = 0.03), and in APOE epsilon4 carriers (p = 0.07). Multivariate analysis suggested that baseline brain parenchymal fraction, HbA1c, and WMH score explain a major proportion of variance in the rates of brain atrophy in the cohort (corrected R2 = 0.27; p = 0.0001).
Conclusions: Neurologically asymptomatic elderly experience continuing brain volume loss, which appears to accelerate with age. Glycated hemoglobin A (HbA1c) was identified as a risk factor for a greater rate of brain atrophy. Clustering of factors associated with the so-called metabolic syndrome in subjects with high HbA1c suggests a link between this syndrome and late-life brain tissue loss.
Similar articles
-
Brain atrophy and white matter hyperintensity change in older adults and relationship to blood pressure. Brain atrophy, WMH change and blood pressure.J Neurol. 2007 Jun;254(6):713-21. doi: 10.1007/s00415-006-0238-4. Epub 2007 Apr 20. J Neurol. 2007. PMID: 17446997 Clinical Trial.
-
The impact of sex and vascular risk factors on brain tissue changes with aging: magnetization transfer imaging results of the Austrian stroke prevention study.AJNR Am J Neuroradiol. 2010 Aug;31(7):1297-301. doi: 10.3174/ajnr.A2042. Epub 2010 Mar 11. AJNR Am J Neuroradiol. 2010. PMID: 20223888 Free PMC article.
-
Vascular risk factors, white matter hyperintensities and hippocampal volume in normal elderly individuals.Dement Geriatr Cogn Disord. 2012;33(1):29-34. doi: 10.1159/000336052. Epub 2012 Feb 24. Dement Geriatr Cogn Disord. 2012. PMID: 22377559
-
Lesion probability maps of white matter hyperintensities in elderly individuals: results of the Austrian stroke prevention study.J Neurol. 2006 Aug;253(8):1064-70. doi: 10.1007/s00415-006-0164-5. Epub 2006 Apr 10. J Neurol. 2006. PMID: 16607471
-
Interaction of APOE e4 and poor glycemic control predicts white matter hyperintensity growth from 73 to 76.Neurobiol Aging. 2017 Jun;54:54-58. doi: 10.1016/j.neurobiolaging.2017.02.014. Epub 2017 Feb 27. Neurobiol Aging. 2017. PMID: 28324763 Free PMC article.
Cited by
-
Mapping brain volume change across time in primary-progressive multiple sclerosis.Neuroradiology. 2024 Jul;66(7):1189-1197. doi: 10.1007/s00234-024-03354-7. Epub 2024 Apr 13. Neuroradiology. 2024. PMID: 38609687
-
A bibliometric analysis of international publication trends in brain atrophy research (2008-2023).Front Neurol. 2024 Jan 31;15:1348778. doi: 10.3389/fneur.2024.1348778. eCollection 2024. Front Neurol. 2024. PMID: 38356880 Free PMC article.
-
Impaired mobility and MRI markers of vascular brain injury: Atherosclerosis Risk in Communities and UK Biobank studies.BMJ Neurol Open. 2024 Jan 24;6(1):e000501. doi: 10.1136/bmjno-2023-000501. eCollection 2024. BMJ Neurol Open. 2024. PMID: 38288313 Free PMC article.
-
Neurodegeneration and its potential markers in the diagnosing of secondary progressive multiple sclerosis. A review.Front Mol Neurosci. 2023 Sep 12;16:1210091. doi: 10.3389/fnmol.2023.1210091. eCollection 2023. Front Mol Neurosci. 2023. PMID: 37781097 Free PMC article. Review.
-
Obesity reduces hippocampal structure and function in older African Americans with the APOE-ε4 Alzheimer's disease risk allele.Front Aging Neurosci. 2023 Sep 4;15:1239727. doi: 10.3389/fnagi.2023.1239727. eCollection 2023. Front Aging Neurosci. 2023. PMID: 37731955 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous